Application of cytochrome P450 BM3 mutants as biocatalysts for the profiling of estrogen receptor binding metabolites of the mycotoxin zearalenone

References

• Bennett JW, Klich M. (2003). Mycotoxins. Clin Microbiol Rev 16:497–516.
   PubMed Web of Science ®Google Scholar
• Berthiller F, Schuhmacher R, Buttinger G, Krska R. (2005). Rapid simultaneous determination of major type A- and B-trichothecenes as well as zearalenone in maize by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 1062:209–216.
   PubMed Web of Science ®Google Scholar
• Biehl ML, Prelusky DB, Koritz GD, Hartin KE, Buck WB, Trenholm HL. (1993). Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicol Appl Pharmacol 121:152–159.
   PubMed Web of Science ®Google Scholar
• Bryden WL. (2007). Mycotoxins in the food chain: human health implications. Asia Pac J Clin Nutr 16 Suppl 1:95–101.
   PubMedGoogle Scholar
• Cavalieri E, Rogan E. (2006). Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann N Y Acad Sci 1089:286–301.
   PubMed Web of Science ®Google Scholar
• Celius T, Haugen TB, Grotmol T, Walther BT. (1999). A sensitive zonagenetic assay for rapid in vitro assessment of estrogenic potency of xenobiotics and mycotoxins. Environ Health Perspect 107:63–68.
   PubMed Web of Science ®Google Scholar
• Charles GD, Bartels MJ, Zacharewski TR, Gollapudi BB, Freshour NL, Carney EW. (2000). Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay. Toxicol Sci 55:320–326.
   PubMed Web of Science ®Google Scholar
• Damsten MC, de Vlieger JS, Niessen WM, Irth H, Vermeulen NP, Commandeur JN. (2008). Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s. Chem Res Toxicol 21:2181–2187.
   PubMed Web of Science ®Google Scholar
• Damsten MC, van Vugt-Lussenburg BM, Zeldenthuis T, de Vlieger JS, Commandeur JN, Vermeulen NP. (2008). Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites. Chem Biol Interact 171:96–107.
   PubMed Web of Science ®Google Scholar
• de Vlieger JS, Kolkman AJ, Ampt KA, Commandeur JN, Vermeulen NP, Kool J, Wijmenga SS, Niessen WM, Irth H, Honing M. (2010). Determination and identification of estrogenic compounds generated with biosynthetic enzymes using hyphenated screening assays, high resolution mass spectrometry and off-line NMR. J Chromatogr B Analyt Technol Biomed Life Sci 878:667–674.
   Google Scholar
• Degen GH, Janning P, Wittsiepe J, Upmeier A, Bolt HM. (2002). Integration of mechanistic data in the toxicological evaluation of endocrine modulators. Toxicol Lett 127:225–237.
   PubMed Web of Science ®Google Scholar
• Duca RC, Bravin F, Delaforge M, Vladescu L, Badea IA, Criste RD. (2009). Development of a new HPLC method used for determination of zearalenone and its metabolites in broiler samples. Influence of zearalenone on the nutritional properties of broiler meat. J Agric Food Chem 57:10497–10504.
   PubMed Web of Science ®Google Scholar
• Eiler S, Gangloff M, Duclaud S, Moras D, Ruff M. (2001). Overexpression, purification, and crystal structure of native ER alpha LBD. Protein Expr Purif 22:165–173.
   Google Scholar
• Fink-Gremmels J. (1999). Mycotoxins: their implications for human and animal health. Vet Q 21:115–120.
   PubMed Web of Science ®Google Scholar
• Hu Y, Kupfer D. (2002). Metabolism of the endocrine disruptor pesticide-methoxychlor by human P450s: pathways involving a novel catechol metabolite. Drug Metab Dispos 30:1035–1042.
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen BS, Katzenellenbogen JA, Mordecai D. (1979). Zearalenones: characterization of the estrogenic potencies and receptor interactions of a series of fungal beta-resorcylic acid lactones. Endocrinology 105:33–40.
   PubMed Web of Science ®Google Scholar
• Kleinova M, Zöllner P, Kahlbacher H, Hochsteiner W, Lindner W. (2002). Metabolic profiles of the mycotoxin zearalenone and of the growth promoter zeranol in urine, liver, and muscle of heifers. J Agric Food Chem 50:4769–4776.
   PubMed Web of Science ®Google Scholar
• Kool J, Ramautar R, van Liempd SM, Beckman J, de Kanter FJ, Meerman JH, Schenk T, Irth H, Commandeur JN, Vermeulen NP. (2006). Rapid on-line profiling of estrogen receptor binding metabolites of tamoxifen. J Med Chem 49:3287–3292.
   Google Scholar
• Krska R, Baumgartner S, Josephs R. (2001). The state-of-the-art in the analysis of type-A and -B trichothecene mycotoxins in cereals. Fresenius J Anal Chem 371:285–299.
   PubMedGoogle Scholar
• Le Guevel R, Pakdel F. (2001). Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. Hum Reprod 16:1030–1036.
   PubMed Web of Science ®Google Scholar
• Malekinejad H, Maas-Bakker R, Fink-Gremmels J. (2006). Species differences in the hepatic biotransformation of zearalenone. Vet J 172:96–102.
   PubMed Web of Science ®Google Scholar
• Malekinejad H, Maas-Bakker RF, Fink-Gremmels J. (2005). Enzyme kinetics of zearalenone biotransformation: pH and cofactor effects. Arch Toxicol 79:547–553.
   PubMed Web of Science ®Google Scholar
• Mirocha CJ, Pathre SV, Robison TS. (1981). Comparative metabolism of zearalenone and transmission into bovine milk. Food Cosmet Toxicol 19:25–30.
   PubMedGoogle Scholar
• Nahoum V, Gangloff A, Shi R, Lin SX. (2003). How estrogen-specific proteins discriminate estrogens from androgens: a common steroid binding site architecture. FASEB J 17:1334–1336.
   Google Scholar
• Olsen M, Kiessling KH. (1983). Species differences in zearalenone-reducing activity in subcellular fractions of liver from female domestic animals. Acta Pharmacol Toxicol (Copenh) 52:287–291.
   PubMedGoogle Scholar
• Olsen M, Pettersson H, Kiessling KH. (1981). Reduction of zearalenone to zearalenol in female rat liver by 3 alpha-hydroxysteroid dehydrogenase. Acta Pharmacol Toxicol (Copenh) 48:157–161.
   PubMedGoogle Scholar
• Olsen M, Pettersson H, Sandholm K, Visconti A, Kiessling KH. (1987). Metabolism of zearalenone by sow intestinal mucosa in vitro. Food Chem Toxicol 25:681–683.
   PubMed Web of Science ®Google Scholar
• Pfeiffer E, Heyting A, Metzler M. (2007). Novel oxidative metabolites of the mycoestrogen zearalenone in vitro. Mol Nutr Food Res 51:867–871.
   Google Scholar
• Pfeiffer E, Hildebrand A, Damm G, Rapp A, Cramer B, Humpf HU, Metzler M. (2009). Aromatic hydroxylation is a major metabolic pathway of the mycotoxin zearalenone in vitro. Mol Nutr Food Res 53:1123–1133.
   Google Scholar
• Reeves CD, Hu Z, Reid R, Kealey JT. (2008). Genes for the biosynthesis of the fungal polyketides hypothemycin from Hypomyces subiculosus and radicicol from Pochonia chlamydosporia. Appl Environ Microbiol 74:5121–5129.
   Google Scholar
• Reinen J, Ferman S, Vottero E, Vermeulen NPE, Commandeur JNM. (2010). Application of a fluorescence-based continuous-flow bioassay to screen for diversity of cytochrome P450 BM3 mutant libraries. J Biomol Screen (In Press).
   Google Scholar
• Sawayama AM, Chen MM, Kulanthaivel P, Kuo MS, Hemmerle H, Arnold FH. (2009). A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. Chemistry 15:11723–11729.
   PubMed Web of Science ®Google Scholar
• Shier WT, Shier AC, Xie W, Mirocha CJ. (2001). Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon 39:1435–1438.
   PubMed Web of Science ®Google Scholar
• Takemura H, Shim JY, Sayama K, Tsubura A, Zhu BT, Shimoi K. (2007). Characterization of the estrogenic activities of zearalenone and zeranol in vivo and in vitro. J Steroid Biochem Mol Biol 103:170–177.
   PubMed Web of Science ®Google Scholar
• Tsuchiya Y, Nakajima M, Yokoi T. (2005). Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 227:115–124.
   PubMed Web of Science ®Google Scholar
• Ueno Y, Tashiro F. (1981). alpha-Zearalenol, a major hepatic metabolite in rats of zearalenone, an estrogenic mycotoxin of Fusarium species. J Biochem 89:563–571.
   PubMedGoogle Scholar
• Välimaa AL, Kivistö AT, Leskinen PI, Karp MT. (2010). A novel biosensor for the detection of zearalenone family mycotoxins in milk. J Microbiol Methods 80:44–48.
   PubMed Web of Science ®Google Scholar
• van Liempd SM, Kool J, Niessen WM, van Elswijk DE, Irth H, Vermeulen NP. (2006). On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators. Drug Metab Dispos 34:1640–1649.
   PubMed Web of Science ®Google Scholar
• van Lipzig MM, Commandeur JN, de Kanter FJ, Damsten MC, Vermeulen NP, Maat E, Groot EJ, Brouwer A, Kester MH, Visser TJ, Meerman JH. (2005). Bioactivation of dibrominated biphenyls by cytochrome P450 activity to metabolites with estrogenic activity and estrogen sulfotransferase inhibition capacity. Chem Res Toxicol 18:1691–1700.
   Google Scholar
• Zinedine A, Soriano JM, Moltó JC, Mañes J. (2007). Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem Toxicol 45:1–18.
   PubMed Web of Science ®Google Scholar
• Zöllner P, Berner D, Jodlbauer J, Lindner W. (2000). Determination of zearalenone and its metabolites alpha- and beta-zearalenol in beer samples by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 738:233–241.
   PubMed Web of Science ®Google Scholar
• Zöllner P, Jodlbauer J, Kleinova M, Kahlbacher H, Kuhn T, Hochsteiner W, Lindner W. (2002). Concentration levels of zearalenone and its metabolites in urine, muscle tissue, and liver samples of pigs fed with mycotoxin-contaminated oats. J Agric Food Chem 50:2494–2501.
   PubMed Web of Science ®Google Scholar